Ian Clements

Insider Reports History

Location
Foster City, CA
Signature
/s/ Jody Howe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Clements:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. Chief Financial Officer Common Stock 30,011 $841,361 $28.04 10 Nov 2022 Direct
Mirum Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 60,000 06 Jan 2022 Direct

Insider Reports Filed by Ian Clements

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MIRM Mirum Pharmaceuticals, Inc. 10 Nov 2022 1 +$5,542 4 Chief Financial Officer 14 Nov 2022, 20:46
MIRM Mirum Pharmaceuticals, Inc. 10 May 2022 1 +$15,262 4 Chief Financial Officer 12 May 2022, 21:14
MIRM Mirum Pharmaceuticals, Inc. 06 Jan 2022 2 $0 4 Chief Financial Officer 07 Jan 2022, 15:52
MIRM Mirum Pharmaceuticals, Inc. 24 Nov 2021 2 +$20,505 4 Chief Financial Officer 29 Nov 2021, 20:49
MIRM Mirum Pharmaceuticals, Inc. 10 Nov 2021 1 +$6,190 4 Chief Financial Officer 15 Nov 2021, 15:16
MIRM Mirum Pharmaceuticals, Inc. 29 Sep 2021 2 -$30,309 4 Chief Financial Officer 01 Oct 2021, 20:00
MIRM Mirum Pharmaceuticals, Inc. 10 May 2021 1 +$14,342 4 Chief Financial Officer 12 May 2021, 17:27